“Huge step backward”: Industry slams FDA’s extension of CBD public comment period

Related Articles

FormattedPicture

BUSINESS NEWS

This week in nutrition news, CRN requests a quick response from the US Food and Drug Administration (FDA) to a citizen petition on NAC status. The Grains & Legumes... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

A producer of phytocannabinoid-rich hemp oils, Verdant Nature, in partnership with US-based CBD brand, HempFusion, has achieved self-affirmed Generally Recognized As... Read More

FormattedPicture

REGULATORY NEWS

The UK’s Advisory Council on the Misuse of Drugs (ACMD)’s new recommendations for the future of consumer CBD products could take a toll on domestic hemp... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Ingredient manufacturer Kemin Industries is investing in US-based hemp producer Driftless Extracts and has entered into a hemp-based product supply agreement.

FormattedPicture

NUTRITION & HEALTH NEWS

CBD extraction retailer Extract Labs is unveiling an Immune Support CBGa (cannabigerolic acid) CBDa (cannabidiolic acid) tincture. The US-based company says these... Read More

trans